working on remediation of various sites & will invite us fda for re-inspection: sun pharma cnbc tv18
Published 3 months ago • 345 plays • Length 4:15Download video MP4
Download video MP3
Similar videos
-
1:00
us fda on sun pharma’s dadra unit: failed to clean, maintain, sanitise equipment at apt intervals
-
3:03
sun pharma dadra unit: us fda warning letter shows multiple repeat observations | n18v | cnbc tv18
-
23:34
sun pharma in focus | us fda to re-inspect halol unit | movers & shakers | cnbc tv18
-
2:33
zydus life dips over 5% after teva gets us fda approval for asacol hd generic | cnbc tv18
-
1:54
sun pharma slips in trade after receiving a warning letter from the us fda for its dadra facility
-
5:32
both high-end and low-end consumers pullback on restaurant spending, says mizuho's baumgartner
-
4:26
pdd founder's wealth drops on cooling sales growth
-
4:02
pinduoduo's stock slump an overreaction, now a good buying opportunity
-
2:38
relief for sun pharma: us fda clears sun pharma's dadra unit
-
1:55
sun pharma mohali unit: u.s. fda flags compliance concerns | halftime report | cnbc-tv18
-
1:15
us fda classifies the inspection at- sun pharma's dadra unit as oai, stock under pressure
-
2:16
sun pharma's halol facility receives u.s. fda warning letter | business lunch | cnbc-tv18
-
23:49
us fda issues 6 observation on sun pharma | halftime report | cnbc-tv18
-
2:36
u.s. fda issues warning letter to sun pharma, questions manufacturing practices at halol facility
-
2:47
sun pharma halol plant | us fda issues 3 observations in form 483 | cnbc tv18
-
1:09
u.s fda woes for sun pharma, gets 6 observations for mohali plant | business lunch | cnbc-tv18
-
1:18
us fda records 11 observations for sun pharma’s dadra facility
-
1:24
sun pharma gets us fda approval for zetia generic
-
5:10
vishal manchanda on impact of u.s fda oai status on sun pharma | bazaar open exchange | cnbc-tv18
-
2:47
not aware of any whistleblower complaint : sun pharma on misgovernance allegations
-
1:23
sun pharma is a buying opportunity and you must keep it: sudarshan sukhani | cnbc tv18
-
1:47
sun pharma on a restructuring drive